Evidence map›Paper›PMID 30317521›Full record

ReviewDrugs2018

Dinoprostone Vaginal Insert: A Review in Cervical Ripening.

Matt Shirley

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Drugs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04743297 (Labour Induction With the Propess Vaginal Delivery System vs. Labour Induction With the Prostin Vaginal Tablet in Case of a Prelabour Rupture of Membranes. PESTIBOR Randomized Controlled Trial), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04743297 phase4unknown statusnot on this mapstarted 2021, after this paper: background citation

Labour Induction With the Propess Vaginal Delivery System vs. Labour Induction With the Prostin Vaginal Tablet in Case of a Prelabour Rupture of Membranes. PESTIBOR Randomized Controlled Trial

TypeinterventionalSponsorUniversity Medical Centre MariborRan2021 to 2023Enrolled526ConditionsPremature Rupture of Membranes at Term, Induction of LabourArmsProstaglandin E2 (Propess), Prostaglandin E2 (Prostin)
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Use of Vaginal Dinoprostone (PGEJournal of clinical medicine · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. [Subgroup identification based on the Logistic model].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Matt ShirleySpringer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. demail@springer.com.
Springer Nature (New Zealand) · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dinoprostone vaginal insert (Cervidil

Indexed as

Cervical RipeningDinoprostoneDose-Response Relationship, DrugDrug Delivery SystemsDrug LiberationFemaleHumansPregnancyRandomized Controlled Trials as TopicTreatment OutcomeDinoprostone

Identifiers

PMID30317521
OpenAlexW2896201083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.